Kevin E. Fisher, MD, PhD
Dr. Fisher's research interests encompass molecular oncology and focus namely on the application of genomic technologies to the diagnosis and management of pediatric solid tumors and hematologic malignancies. His clinical interests focus on the development and implementation of combined targeted next-generation sequencing and cytogenetic assays to provide diagnostic and prognostic information for pediatric patients with acute leukemia.
Fisher KE, Cohen C, Siddiqui MT, Palma JF, Lipford EH 3rd, Longshore JW. Accurate detection of BRAF p.V600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays. Human Pathology 2014 Aug 7. View All Publications: http://www.ncbi.nlm.nih.gov/pubmed?term=Fisher%2C%20Kevin%20E%5BAuthor%…
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.